Similar to the comparison between binge drinkers and non-binge drinkers, a nominally significant genetic effect was identified for maternal variant rs869978 for binge drinkers versus non-drinkers (p = 0.0242).
Excerpts
tropicalis , FLU and VOR displayed near-significant increasing trends (raw p = 0.0242 and 0.0280), but adjusted values (0.0968) fell above threshold; CAS and MIF showed no relevant trends (Fig. 3 d).
A small and slightly significant difference ( p = 0.0243) was observed upon mutation of both the G-box and GATA elements, however a triple mutant (G-box, GATA, and CAAT) was not significantly different than ELIP1 WT.
This corresponds to an error rate of 24 of 762,174 or 0.0031% for WES, which shows a marginally significant increase as compared to the Sanger rate (Poisson exact ratio test ( P = 0.02431) of rate ratio = 1).
Of note, 3-year OS and PFS in fit/intermediate versus frail patients showed highly significant differences of 86% (95% CI: 81-90) versus 70% (95% CI: 47-85) and 57% (95% CI: 50-63) versus 21% (95% CI: 6-41), respectively ( P =0.0245/ P <0.0001).
did not quite reach significancep = 0.0245
However, the increase in the ratio of pNF-κB/ NF-κB in the combination treatment group did not quite reach significance (control 0.59 ± 0.12; H398, 0.69 ± 0.13; EHD-sc-mTNF R2 1.00 ± 0.03, p = 0.0245; H398 + EHD-sc-mTNF R2, 0.94 ± 0.057) (Fig. 4 J–L).
However, the difference between these two trial types was only marginally significant, M diff = 31.2 ms, t (572.4) = 0.94, p = .0245, β z = 0.02.
However, this was only weakly significant [ p = 0.0245 and 0.0148].
Analyzing the histological type of the MMMT, homologous type was a protective factor for death (OR=0.3472) while heterologous type could be considered a risk factor (OR=2.880), both parameters being extremely significant (P=0.0247).
The analysis of AHR expression in the UT-7/11 cell line expressing high levels of BCR-ABL, showed reduced levels of AHR mRNA (28-fold decrease) as compared to parental UT-7 cells and this was highly significant (p = 0.0247, Student’s t-test, Fig 1B ).
The 24-h body weight showed a trend of reduction, but this change did not reach statistical significance upon GALP treatment ( p = 0.0247) (Fig. 6 b).
showed a trendp = 0.0248
3 ), but women showed a trend towards longer ICU/CCU stays [mean (SD), 4.05 (7.67) days vs. 3.51 (6.63) days, p = 0.0248] and total initial hospital stays [10.37 (9.62) days vs. 9.87 (9.17) days, p = 0.0258] compared to men.
In the case of IL-9, even though a decreasing trend was observed after IgY treatments, the values still remain significantly higher than in controls (241.0 ± 41.9, p = 0.0248 for PSO-PIgY and 293.5 ± 114.5, p = 0.0139 for PSO-IgY).
We observed a significant and borderline significant increase in body weight of F3 relative to F2 or F1 PAA offspring ( p = 0.0248 and p = 0.0596, respectively).
JPH3:RyR1 versus JPH3:RyR3 is borderline significant (p=0.0248) and JPH4:RyR2 versus JPH4:RyR1 is not significant (p=0.2366). 6.
Efficacy end points in the ITT population Primary end point The difference in the average slope of change in 6MWD over 72 weeks between the ataluren and placebo groups was nominally significant (-0.74 m/week and -0.94 m/week in the ataluren and placebo groups, respectively; difference [95% CI]: 0.20 [0.03, 0.38]; p = 0.0248), equivalent to a 21% slower rate of decline in the ataluren group ( Table 3 ).
Although no significant genetic loci were found in this analysis and only one of our Resilience genetic loci was nominally significant in the HRS GWAS (chromosome 3 locus; p = 0.025), there was a significant genetic correlation ( r g = −0.65, p = 1.5 × 10 −3 ) between cognitive change and Resilience .
approached significancep = 0.025
The difference between MRE and hydro-US approached significance ( z = 2.245, p = 0.025) (Supplementary Table 2 ).
Syphilis and venereal disease had an increasing trend (P=0.025 and <0.01 respectively).
Statistically, the difference between VtoV values in the period 1979–2009 and those in 2010–2014 is slightly significant ( p = 0.025); values in 2010–2014 do not result to be different from those in the time span 2015–2021 ( p > 0.05).
More precisely, we found cognitive abilities being marginally significant ( adjusted p = 0.025) and, along with COVID-19 interest, related to an increased tendency to report true memories.
approached significancep < .025
Only errors designated as ‘inappropriate situation for administration/ not indicated’, approached significance at the p < .025 level with a decrease of 92.9% (pre-MACC: M = .52, SD = 1.22; post-MACC: M = .04, SD = .19; p = .027).
As predicted, pairwise comparisons revealed the mean difference in intended consumption was significantly larger between portion sizes in the pair that crossed the lower norm boundary than between portion size pairs that fell inside of the norm range, Study 1: MD difference in intended consumption between paired portion sizes = 0.20, SE = 0.05, p < .001, but this comparison was only borderline significant (against Bonferroni-adjusted α = 0.025) in Study 2, MD = 0.31, SE = 0.13, p = .025.
Posttreatment levels of groups A and B are not significantly different from each other (p = 0.581), whereas the difference between the posttreatment levels of group B and the non-malignant controls (group C) is slightly significant (p = 0.025).
High distress and comorbidities were associated with greater WB-MRI burden in adjusted analyses, with deprivation only approaching significance (adjusted regression β = 0.223, p = 0.025; β = 0.191, p = 0.048; β = −0.186, p = 0.059 respectively).